Renacer-3 (Retatrutide) 20 Mg

Retatrutide is an investigational once-weekly injectable medication.It is often called a “triple agonist” because it activates three hormone receptors:

1. GLP-1 (Glucagon-Like Peptide-1)
2. GIP (Glucose-Dependent Insulinotropic Polypeptide)
3. Glucagon

This three-hormone approach is designed to reduce appetite, improve blood sugar control, and increase energy expenditure, potentially leading to greater weight loss than current GLP-1 medications.

---

Key Benefits

Significant Weight Loss

Clinical trials have shown some of the largest weight-loss results ever reported for an obesity medication.

• Up to 28.3% average body weight loss after 80 weeks at the highest dose.
• Some participants lost over 30% of their body weight.
• Average weight loss exceeded 70 pounds in higher-dose groups.

Appetite Reduction

Retatrutide helps:

• Reduce hunger
• Increase fullness after meals
• Decrease food cravings
• Support lower calorie intake

Blood Sugar Improvements

In Phase 3 diabetes studies:

• A1C reductions of approximately 1.7%–2.0%
• Improved glucose control
• Significant weight reduction alongside diabetes management

Cardiometabolic Benefits

Studies have reported improvements in:

• Waist circumference
• Triglycerides
• Blood pressure
• Inflammatory markers (hs-CRP)
• Non-HDL cholesterol levels